The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.

Reference: WO/2013/110818; PCT/EP2013/051596
Priority Date: 27 Jan 2012
Publication date: 1 Aug 2013
Granted: US, AU, China, Israel, Japan, Republic of Korea, Mexico, New Zealand, Russian Federation, South Africa
Pending: Brazil, Hong Kong
Published: Canada, India
Case inactive: EP  
Licensed to: Aelix Therapeutics